Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells
Huldani Huldani, Ria Margiana, Fawad Ahmad, et al.
International Immunopharmacology (2022) Vol. 107, pp. 108698-108698
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis
Airu Liu, Xiaonan Liang, Wenxin Wang, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
m6A modification in inflammatory bowel disease provides new insights into clinical applications
Jiamin Zhang, Bimei Song, Yue Zeng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114298-114298
Open Access | Times Cited: 24
The role of amino acid metabolism in inflammatory bowel disease and other inflammatory diseases
Xiaowen Zheng, Yi Zhu, Zihan Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
The developing role of extracellular vesicles in autoimmune diseases: special attention to mesenchymal stem cell-derived extracellular vesicles
Geovanny Genaro Reiván Ortiz, Neelam Hazoor Zaidi, Ravinder Saini, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110531-110531
Closed Access | Times Cited: 20
Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease
Shulin Wei, Mingxing Li, Qin Wang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3307-3334
Open Access | Times Cited: 7
Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota
Fan Yang, Beibei Ni, Qiuli Liu, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Heterogeneity of mesenchymal stem cells as a limiting factor in their clinical application to inflammatory bowel disease in dogs and cats
Takahiro Teshima
The Veterinary Journal (2024) Vol. 304, pp. 106090-106090
Open Access | Times Cited: 6
Unlocking the versatile potential: Adipose-derived mesenchymal stem cells in ocular surface reconstruction and oculoplastics
Pier Luigi Surico, Anna Scarabosio, Giovanni Miotti, et al.
World Journal of Stem Cells (2024) Vol. 16, Iss. 2, pp. 89-101
Open Access | Times Cited: 5
TNF-α Enhances the Therapeutic Effects of MenSC-Derived Small Extracellular Vesicles on Inflammatory Bowel Disease through Macrophage Polarization by miR-24-3p
Huikang Xu, Jiamin Fu, Lijun Chen, et al.
Stem Cells International (2023) Vol. 2023, pp. 1-28
Open Access | Times Cited: 13
Mesenchymal Stem Cells Ameliorate DSS-Induced Experimental Colitis by Modulating the Gut Microbiota and MUC-1 Pathway
Han Wang, Yang Sun, Fengjun Xiao, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 2023-2039
Open Access | Times Cited: 12
Mesenchymal stem cells inhibit ferroptosis by activating the Nrf2 antioxidation pathway in severe acute pancreatitis-associated acute lung injury
Hongfang Yang, Yan Liu, Jiaqi Yao, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176380-176380
Open Access | Times Cited: 4
Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders
Pier Luigi Surico, Vincenzo Barone, Rohan Bir Singh, et al.
Survey of Ophthalmology (2024) Vol. 70, Iss. 3, pp. 467-479
Open Access | Times Cited: 4
Wall of Resilience: How the Intestinal Epithelium Prevents Inflammatory Onslaught in the Gut
Eva Liebing, Susanne M. Krug, Markus F. Neurath, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024), pp. 101423-101423
Open Access | Times Cited: 4
Advances and prospects of tumor immunotherapy mediated by immune cell-derived biomimetic metal-organic frameworks
Huining Ding, Qing Xia, Jiaqi Shen, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 232, pp. 113607-113607
Closed Access | Times Cited: 10
YAP1 mediates the dimensional and chemical coordination of immunoregulation and therapy in extensively passaged mesenchymal stem cells
Fangying Du, Feng Zhou, Na Zhao, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1930-1948
Open Access
Distinct molecular properties and functions of small EV subpopulations isolated from human umbilical cord MSCs using tangential flow filtration combined with size exclusion chromatography
Wei Liu, Xinyu Wang, Yating Chen, et al.
Journal of Extracellular Vesicles (2025) Vol. 14, Iss. 1
Open Access
Innovative therapeutic strategies for intrauterine adhesions: Role of umbilical cord mesenchymal stem cells in rat models
Mingle Zhang, He Gao, Jiahua Zheng, et al.
Experimental and Therapeutic Medicine (2025) Vol. 29, Iss. 3
Open Access
Mesenchymal Stem Cells Armed with DNA Nanorobots as a Modality for Combination Therapy of Inflammatory Bowel Disease
Hongxiu Yuan, Gang Wang, Fangbo Zou, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
VCAM-1 as a common biomarker in inflammatory bowel disease and colorectal cancer: unveiling the dual anti-inflammatory and anti-cancer capacities of anti-VCAM-1 therapies
Jessica R. Pickett, Yuao Wu, Hang T. Ta
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 2
Open Access
Indoleamine-2,3-dioxygenase: An important controller in maintaining mesenchymal stem cell-mediated immunomodulatory homeostasis
Y. H. Hui, Xue Jiao, Li Yang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Mesenchymal Stem Cells in the Treatment of COVID-19
Bei-Cyuan Guo, Kang‐Hsi Wu, Chun‐Yu Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14800-14800
Open Access | Times Cited: 8
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Jiaxi Zhao, Rong Chen, Mengqi Luo, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Hydrogels in Gene Delivery Techniques for Regenerative Medicine and Tissue Engineering
Kexing Xu, Qinmeng Zhang, Danji Zhu, et al.
Macromolecular Bioscience (2024) Vol. 24, Iss. 6
Closed Access | Times Cited: 3
In situ licensing of mesenchymal stem cell immunomodulatory function via BMP-2 induced developmental process
Fuwei Zhu, Luli Ji, Kai Dai, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 48
Open Access | Times Cited: 3
A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances
Maheeba Abdulla, Nafeesa Mohammed
Biologics (2022) Vol. Volume 16, pp. 129-140
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top